
home All News open_in_new Full Article
Experimental drug may PREVENT Alzheimer's in potential breakthrough

A study suggests an experimental drug, gantenerumab, may prevent early-onset Alzheimer's in individuals genetically predisposed to the disease by targeting amyloid proteins in the brain. The drug halved the risk of developing the condition in asymptomatic patients after eight years of treatment. While gantenerumab is no longer being developed, researchers believe similar anti-amyloid drugs could lead to future prevention and treatment options for Alzheimer's patients.
today 15 h. ago attach_file Events
attach_file
Economics
attach_file
Economics
attach_file
Politics
attach_file
Events
attach_file
Society
attach_file
Events
attach_file
Politics
attach_file
Events
attach_file
Events
attach_file
Politics
attach_file
Events
attach_file
Events
attach_file
Economics
attach_file
Events
attach_file
Politics
attach_file
Society
attach_file
Politics
attach_file
Economics
attach_file
Events
attach_file
Economics
ID: 1414540163